Scientists Find How Alzheimer's Spreads Through the Brain

Scientists at the University of Utah have uncovered a promising new clue about how Alzheimer's disease spreads through the brain, and it could change how we fight this devastating condition.

The breakthrough centers on a protein called Arc, which normally helps brain cells communicate with each other. Researchers discovered that Arc accidentally gives toxic Alzheimer's proteins a ride from diseased neurons into healthy ones, spreading the condition throughout the brain.

Dr. Jason Shepherd, who led the study, calls it an exciting development. His team found that Arc packages itself into tiny bubble-like vessels that travel between neurons, and toxic Tau proteins hitch a ride along the way.

In Alzheimer's disease, Tau proteins clump together into sticky tangles that kill brain cells. When these tangles break into smaller pieces called Tau seeds, they can corrupt healthy Tau proteins in neighboring cells, starting the destructive process all over again.

The research team tested their theory in mice with Alzheimer's disease. When they removed the Arc protein, toxic Tau could barely spread between brain cells. The transfer was almost completely gone.

But Arc isn't simply a villain in this story. The protein also helps sick neurons survive longer by allowing them to expel excess toxic Tau. Without Arc, the toxic proteins get trapped inside diseased cells, killing them faster.

This dual role suggests that the best treatment approach might not be blocking Arc entirely. Instead, future therapies could intercept the toxic packages after they leave sick cells but before they reach healthy ones.

Why This Inspires

This discovery offers real hope for the millions of families affected by Alzheimer's disease. While current treatments can't reverse brain damage, stopping the spread of toxic proteins could slow or even halt the disease's progression in its early stages.

The researchers found the same Arc and Tau combination in human brain tissue, suggesting this mechanism exists in people, not just mice. That makes it a viable target for future treatments.

For someone diagnosed with early Alzheimer's or dementia, a therapy that prevents further spread could mean more years of clear thinking and precious time with loved ones.

The road from laboratory discovery to actual treatment is long, and Dr. Shepherd emphasizes they're still far from developing a therapy. But identifying this new pathway gives scientists a concrete target to aim for, something that didn't exist before.

After decades of frustration in Alzheimer's research, this discovery represents genuine progress in understanding how the disease works and where we might finally be able to stop it.